What are the implications of these findings? Dr. Ben Readhead, a co-founder of the project, discussed the results and their potential implications.
“We believe we have identified a biologically distinct subtype of Alzheimer’s that may impact 25–45% of individuals with this illness,” he said.
Further investigation is required to support the validity of the study’s conclusions. Eventually, however, it can lead to new measures being taken to avoid the illness altogether.
In the end, current antiviral medications may be investigated for the treatment or prevention of this kind of Alzheimer’s disease.
Blood tests that are now being developed are thought to be able to assist in identifying people who are infected with HCMV.
